hank kung

hank kung

University of Pennsylvania

H-index: 91

North America-United States

About hank kung

hank kung, With an exceptional h-index of 91 and a recent h-index of 31 (since 2020), a distinguished researcher at University of Pennsylvania, specializes in the field of medicinal chemistry, radiochemistry, nuclear medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

Determining the optimal pharmacokinetic modelling and simplified quantification method of [18F]AlF-P16-093 for patients with primary prostate cancer (PPCa)

First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients

Comparison of novel PSMA-targeting [177Lu] Lu-P17-087 with its albumin binding derivative [177Lu] Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a …

First-in-human study of D6-[18F] FP-(+)-DTBZ, a novel VMAT2 tracer: whole-body biodistribution and brain PET comparison with [18F] FP-(+)-DTBZ (AV-133)

Serotonin transporter imaging agent as a probe for β-cells of pancreas

Optimization and scale up of production of the PSMA imaging agent [18F]AlF-P16-093 on a custom automated radiosynthesis platform

A prospective head-to-head comparison of [68Ga] Ga-HBED-CC-BP and [68Ga] Ga-PSMA-11 PET/CT in patients with bone metastases from prostate cancer

Head-to-head comparison of 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT in patients with primary prostate cancer: a pilot study

hank kung Information

University

Position

___

Citations(all)

28818

Citations(since 2020)

4749

Cited By

25878

hIndex(all)

91

hIndex(since 2020)

31

i10Index(all)

325

i10Index(since 2020)

103

Email

University Profile Page

University of Pennsylvania

Google Scholar

View Google Scholar Profile

hank kung Skills & Research Interests

medicinal chemistry

radiochemistry

nuclear medicine

Top articles of hank kung

Title

Journal

Author(s)

Publication Date

Determining the optimal pharmacokinetic modelling and simplified quantification method of [18F]AlF-P16-093 for patients with primary prostate cancer (PPCa)

European Journal of Nuclear Medicine and Molecular Imaging

Ruiyue Zhao

Zeheng Xia

Miao Ke

Jie Lv

Huizhen Zhong

...

2024/1/29

First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients

European Journal of Nuclear Medicine and Molecular Imaging

Ruiyue Zhao

Miao Ke

Jie Lv

Shaoyu Liu

Yuheng Liu

...

2024/1/12

Comparison of novel PSMA-targeting [177Lu] Lu-P17-087 with its albumin binding derivative [177Lu] Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a …

European Journal of Nuclear Medicine and Molecular Imaging

Linlin Li

Jiarou Wang

Guochang Wang

Rongxi Wang

Wenbin Jin

...

2024/4/25

First-in-human study of D6-[18F] FP-(+)-DTBZ, a novel VMAT2 tracer: whole-body biodistribution and brain PET comparison with [18F] FP-(+)-DTBZ (AV-133)

Ruiyue Zhao

Jinhua Chen

Ting Ye

Jianmin Chu

Hank F Kung

...

2024/2/28

Serotonin transporter imaging agent as a probe for β-cells of pancreas

Nuclear Medicine and Biology

Yuli Sun

Guangwen Li

Haiyan Hong

Lin Zhu

Hank F Kung

...

2024/2/24

Optimization and scale up of production of the PSMA imaging agent [18F]AlF-P16-093 on a custom automated radiosynthesis platform

EJNMMI Radiopharmacy and Chemistry

David Alexoff

Seok Rye Choi

Karl Ploessl

Dohyun Kim

Ruiyue Zhao

...

2024/2/23

A prospective head-to-head comparison of [68Ga] Ga-HBED-CC-BP and [68Ga] Ga-PSMA-11 PET/CT in patients with bone metastases from prostate cancer

Jiarou Wang

Guochang Wang

Linlin Li

Zhaohui Zhu

Lin Zhu

...

2023/6/1

Head-to-head comparison of 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT in patients with primary prostate cancer: a pilot study

Clinical Nuclear Medicine

Guochang Wang

Linlin Li

Jie Zang

Haiyan Hong

Lin Zhu

...

2023/4/1

Head-to-head comparison of [68Ga]Ga-P16-093 and 2-[18F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot study

European Journal of Nuclear Medicine and Molecular Imaging

Guochang Wang

Linlin Li

Jiarou Wang

Jie Zang

Jingci Chen

...

2023/4

[18F]‐D3FSP amyloid‐β PET imaging in elderly adults and Alzheimer’s disease

Alzheimer's & Dementia

Anqi Li

Ruiyue Zhao

Mingkai Zhang

Pan Sun

Yue Cai

...

2023/12

[68Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake

Molecular Pharmaceutics

Haiyan Hong

Zhihao Zha

Ruiyue Zhao

Yang Luo

Wenbin Jin

...

2023/3/21

Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy

Journal of Medicinal Chemistry

Zhihao Zha

Karl Ploessl

Seok Rye Choi

Ruiyue Zhao

Wenbin Jin

...

2023/9/5

Assessing extra-prostatic extension for surgical guidance in prostate cancer: Comparing two PSMA-PET tracers with the standard-of-care

Urologic oncology: seminars and original investigations

Clinton D Bahler

Mark A Green

Mark A Tann

Jordan K Swensson

Katrina Collins

...

2023/1/1

A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer

European Journal of Nuclear Medicine and Molecular Imaging

Guochang Wang

Linlin Li

Ming Zhu

Jie Zang

Jiarou Wang

...

2023/8

In vivo and in vitro binding of [125I]I‐R‐(+)‐TISCH: A dopamine D1 receptor ligand for studying pancreatic β‐cell mass

Journal of Labelled Compounds and Radiopharmaceuticals

Yan Zhang

Guangwen Li

Yuli Sun

Haiyan Hong

Linlin Li

...

2022/12

Head-to-head comparison of [68 Ga]Ga-P16-093 and [68 Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients

European Journal of Nuclear Medicine and Molecular Imaging

Guochang Wang

Haiyan Hong

Jie Zang

Qingxing Liu

Yuanyuan Jiang

...

2022/2/1

Preliminary Evaluation of 68Ga-P16-093, a PET Radiotracer Targeting Prostate-Specific Membrane Antigen in Prostate Cancer

Molecular Imaging and Biology

Hwan Lee

Joshua S Scheuermann

Anthony J Young

Robert K Doot

Margaret E Daube-Witherspoon

...

2022/10

New PSMA-Targeting Ligands: Transformation from Diagnosis (Ga-68) to Radionuclide Therapy (Lu-177)

Journal of Medicinal Chemistry

Zhihao Zha

Seok Rye Choi

Linlin Li

Ruiyue Zhao

Karl Ploessl

...

2022/9/14

PD27-01 PREDICTING EXTRA-PROSTATIC EXTENSION (EPE) FOR SURGICAL GUIDANCE IN PROSTATE CANCER: A COMPARISON OF BIOPSY PATHOLOGY, MULTIPARAMETRIC MRI, AND PSMA-PET

The Journal of Urology

Clinton Bahler

Mark Green

Mark Tann

Katrina Collins

Jordan Swensson

...

2022/5

Prostate-specific membrane antigen (psma) inhibitors as diagnostic and radionuclide therapeutic agents

2022/4/28

See List of Professors in hank kung University(University of Pennsylvania)